Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015

Basic Details
Date Posted
Friday, April 16, 2021
Status
Complete
Medical Product
new molecular entities (NMEs)
Description

In this report we described baseline characteristics and the duration of follow-up time among new users of 39 new molecular entities (NMEs) approved in 2014 and 45 NMEs approved in 2015 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).

Additional Details
FDA Center
CDER
Time Period
January 1, 2014 - August 31, 2018
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)